Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Methylenecyclopropanes. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN108129287B discloses a novel FeCl2-catalyzed radical cyclization of methylenecyclopropanes and aldehydes, offering a cost-effective route for high-purity pharmaceutical intermediates.